| EMED Mining Public Limited ("EMED" or the "Company") Notification of a Change in Shareholding | |
| | |
|
NICOSIA, CYPRUS--(Marketwired - Nov 6, 2014) - EMED Mining Public Limited (TSX: EMD) (AIM: EMED) -- The Company has been notified that Trafigura Beheer B.V. ("Trafigura") has, through its wholly owned indirect subsidiary Urion Holdings (Malta) Limited ("Urion"), acquired 19,565,000 ordinary shares ("Ordinary Shares") of EMED on 3 November 2014. Trafigura now exercises control or direction over an aggregate of 278,594,997 Ordinary Shares, representing approximately 19.35% of the outstanding Ordinary Shares.
Enquiries
EMED Mining |
|
Isaac Querub/Alberto Lavandeira/John Leach |
|
+34 959 59 28 50 |
Canaccord Genuity |
|
Neil Elliot/Mark Palmer |
|
+44 207 523 8000 |
Fox-Davies Capital |
|
Oliver Stansfield |
|
+44 203 463 5061 |
Walbrook PR |
|
Nick Rome |
|
+44 207 933 8783 |
|
|
|
|
|
For further information on the Company's activities, visit www.emed-mining.com.
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |